Rivian Automotive, Inc. is an American electric vehicle manufacturer founded in 2009 by Robert "RJ" Scaringe. Headquartered in Irvine, California, Rivian focuses on producing electric trucks and SUVs designed for sustainability. Its flagship models include the R1T, an all-electric pickup truck, and the R1S, an all-electric SUV, both known for their powerful electric motors and impressive performance capabilities. In addition to vehicle manufacturing, Rivian develops automotive technology, particularly in electric drivetrains and autonomous driving systems. The company is also exploring opportunities in ride-sharing and driverless car markets. Rivian has garnered significant investment from major corporations, including Amazon, which has placed large orders for electric delivery vans, and Ford Motor Company. With a strong focus on innovation and sustainability, Rivian aims to meet the growing demand for electric vehicles in both consumer and commercial markets.
MGT is a national technology and advisory solutions leader serving state, local government, education (SLED) and targeted commercial clients. Our specialized solutions solve the most critical issues that live at the top of our clients leadership agenda. We partner to help clients build resilience, implement systematic change and strengthen their foundations, now and for the future. MGT is committed to impacting communities for good. For more information, visit us at mgt.us.
BenefitHelp brings a menu of innovative solutions to help employers control costs and achieve a healthier, happier, more productive workforce. We use proven processes and technologies that help employers communicate, enroll, and administer their employee benefits programs. BenefitHelp has a range of services that address the entire benefit package, multi-media communication tools like the BenefitMOVIE www.BenefitMOVIE.com, multiple enrollment solutions, and a full benefit administration systems. Todays environment mandates that employers and employees become more educated consumers of Health Care & Benefit Plans. Our goal is to enhance the value of businesses by providing them innovative solutions that bring cost savings, education and benefit enrichment. As stated by Mark Holland, CEO,: "With our service everybody wins. Employers benefit because the employees better understand and appreciate their benefit package, as well as how much the employer spends; and employees benefit because they now understand and appreciate their benefits and how to use them." Studies show that people generally remember 10% of what they read, 10% of what they hear, 30% of what they see, and 50% of what they see and hear. Our multimedia approach provides the optimal solution because employees are reading, seeing, and hearing about their benefits. Visit us: www.BenefitHELP.com www.BenefitHELP.com/HowWeHelp.aspx www.BenefitMOVIE.com
Herspiegel is a consulting firm based in Pennsylvania, founded in 2007, that specializes in pharmaceutical and biotech commercialization services. With over fifteen years of experience, the company has supported more than 150 product launches across various therapeutic areas, including primary care, oncology, and rare diseases. Their mission is to create a model for successful pharmaceutical product launches. The firm offers a wide range of services tailored to the life sciences industry, including market access, medical affairs, marketing strategy, and operational execution. Herspiegels team consists of over 350 experts, including MDs, PhDs, MBAs, and pharmacists, who provide deep knowledge to help clients navigate complex challenges and maximize brand potential. They serve a diverse clientele, from startups to large global pharmaceutical companies, focusing on strategic insights and operational excellence to enhance commercial success and patient outcomes. Herspiegel has also expanded its capabilities through strategic acquisitions, such as Decisive Consulting, which enhances their market access and value strategy services. This positions Herspiegel to deliver innovative solutions in a dynamic pharmaceutical landscape.